CXCR2 and breast carcinoma: To determine the role of CXCR2 signaling in the tumor-bone interface, we utilized an experimental osteolytic bone metastasis model; implanting the breast cancer cells on the dorsal calvaria of mice and evaluating the tumor growth, bone destruction index, and osteoclast activation (Figure 1A).